• General Dermatology
  • Eczema
  • Chronic Hand Eczema
  • Alopecia
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Melasma
  • NP and PA
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Prurigo Nodularis

Slideshow

A quick guide to the February issue

Author(s):

Dermatology Times Staff

Read the highlights from our February 2020 issue in the slideshow below.

Read the highlights from our February 2020 issue in this slideshow.

Related Videos
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Related Content
Adverse Events from Apremilast Contribute to Provider Burden, New Survey Reveals
December 4th 2024

Adverse Events from Apremilast Contribute to Provider Burden, New Survey Reveals

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients
August 2nd 2024

The Cutaneous Connection: Intervening in AD Progression for Pediatric Patients

Comparing Effectiveness of Risankizumab and Deucravacitinib in Plaque Psoriasis
December 4th 2024

Comparing Effectiveness of Risankizumab and Deucravacitinib in Plaque Psoriasis

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis
July 1st 2024

The Cutaneous Connection: Navigating Systemic Therapies in Atopic Dermatitis

Apogee Announces Clinical Trial Advancements in APG777 for AD Treatment
December 3rd 2024

Apogee Announces Clinical Trial Advancements in APG777 for AD Treatment

Reviewing Key Clinician Insights and Innovations in Vitiligo Care This Year
December 3rd 2024

Reviewing Key Clinician Insights and Innovations in Vitiligo Care This Year

© 2024 MJH Life Sciences

All rights reserved.